Anifrolumab: the new frontier in the treatment of genetic interferonopathies
Marie‐Louise Frémond, C. David, Christophe Richez
Abstract
Understanding the precise mechanisms of monogenic autoinflammatory diseases provides crucial insights into the complex pathophysiology of more common multifactorial diseases, while treatments developed for these prevalent conditions hold promising potential to tackle rare genetic disorders.
Topics & Concepts
MedicineFrontierBioinformaticsHistoryArchaeologyBiologySystemic Lupus Erythematosus Researchinterferon and immune responsesOcular Diseases and Behçet’s Syndrome